HKSH Medical Group Strengthens Collaboration with United Imaging Introducing Hong Kong’s First Total-Body PET/CT System to Strengthen “Dual-Tracer” in Nuclear Medicine and Advance Innovation in Cancer Theranostics
Learn More
HKSH Participates in World Cancer Congress 2026
Learn More
HKSH Medical Group Collaborates with Standard Chartered to Launch an Intergenerational Health Management Solution for High-Net-Worth Clients
Learn More
HKSH Signs Energy Saving Charter 2026 and 4T Charter Building a Sustainable Low-carbon Healthcare Environment
Learn More
HKSH’s First-in-Asia Comparative Study on Radiotherapy for Breast Cancer Reveals Hypofractionated Proton Therapy Prevents Breast Cancer Recurrence with 100% Survival Rate Minimises Cardiopulmonary Concerns and Maintains Quality of Life
Learn More
HKSH Family Medicine and Primary Care Centre (Admiralty) Service Commences on 4 June 2026
Learn More
HKSH Collaborates with HSBC to Advocate Early Investment in Health Capital Regular Screening to Manage "Health Assets" for Healthy Families and Healthy Ageing
Learn More
HKSH Medical Group Named Asia’s first Photon-Counting CT Simulator Reference Site Bringing Global Impacts on Precision Medicine and Medical Imaging with Siemens Healthineers
Learn More
HKSH Village Volunteers Raised HK$500,000 for Charles K. Kao Foundation To Support Free Community Screening for Dementia Enabling Early Detection to Alleviate Burden for Patients and Caregivers
Learn More
Asia’s First Study: 5 Sessions of Proton Therapy to Control Early-Stage Prostate Cancer HKSH Cancer Centre’s Precision Targeting Technologies Leading the Evolution of “Hypofractionation”
Learn More
